Home / Clinical Guideline Hubs / Chapter 15.3
Section 15 — Biostatistics & Evidence-Based Medicine Board-prep reference v1.0 · July 2026

Chapter 15.3 — Measures of Effect & Association

Relative risk, odds ratio, ARR, RRR, and number needed to treat · A board-prep reference

Educational reference. Statistical concepts for exam preparation, not patient-specific clinical instructions.
QUICK-REFERENCE BOX — Relative vs Absolute

1. Overview

The Core Idea

Measures of effect quantify how much an exposure or treatment changes the risk of an outcome. Relative measures express the size of the association; absolute measures express what that means for real patients. Reporting only relative measures is the classic way to make a small effect sound large.

2. Relative Measures

RR, OR, RRR
  • Relative risk (RR) = risk in exposed / risk in unexposed. RR = 1 → no association; >1 → harm; <1 → protection. Used in cohort studies and RCTs.
  • Odds ratio (OR) = odds of exposure in cases / odds in controls. Used in case-control studies; approximates RR when the outcome is rare.
  • Relative risk reduction (RRR) = ARR / control event rate — the proportional reduction; can look large even when ARR is small.

3. Absolute Measures

ARR
  • Absolute risk reduction (ARR) = control event rate − treatment event rate — the actual reduction in risk.
  • ARR reflects the real-world benefit and depends on baseline risk (higher-risk patients gain more).

4. Number Needed to Treat / Harm

NNT & NNH
  • NNT = 1 / ARR — patients treated to prevent one additional bad outcome (always round up).
  • NNH = 1 / absolute risk increase — patients exposed to cause one additional harm.
  • A smaller NNT means a more clinically valuable treatment.

5. Worked Example

MeasureCalculationResult
Control event rate—10%
Treatment event rate—5%
Relative risk (RR)5% / 10%0.5
Relative risk reduction (RRR)(10% − 5%) / 10%50%
Absolute risk reduction (ARR)10% − 5%5%
Number needed to treat (NNT)1 / 0.0520
The Lesson

A "50% relative risk reduction" sounds dramatic, but the absolute reduction is only 5% and you must treat 20 patients to prevent one event. Same data, very different impression.

6. Interpreting Them

At the Bedside
  • Always look for absolute numbers alongside relative ones.
  • Remember NNT depends on baseline risk — the same drug helps high-risk patients more.
  • Check the confidence interval around the estimate (see 15.4) — it conveys precision.

7. Key Pearls

High-Value Points
  • RR/OR describe strength; ARR/NNT describe clinical impact.
  • NNT = 1/ARR (round up); smaller NNT = more useful treatment.
  • OR ≈ RR only when the outcome is rare.
  • A big RRR with a small ARR is the classic way to oversell a therapy.
  • NNT falls (benefit rises) as baseline risk increases.

8. Common Mistakes to Avoid

Misreadings & Better Practice

Frequent errors with effect measures.

MistakeWhy it's wrongBetter reading
Quoting RRR alone.Hides small absolute benefit.Report ARR and NNT too.
Treating OR as RR in a common outcome.OR overstates RR when outcome is frequent.Use RR from cohort/RCT data.
Ignoring baseline risk for NNT.NNT is not universal.Interpret NNT for the relevant risk group.

9. Board-Style High-Yield Summary

Key Takeaways
  • RR = risk ratio (cohort/RCT); OR = odds ratio (case-control), ≈ RR when outcome rare.
  • ARR = control − treatment event rate; RRR = ARR / control rate.
  • NNT = 1/ARR (round up); NNH = 1/ARI.
  • Relative measures can exaggerate; always weigh absolute measures.
  • NNT depends on baseline risk.

10. References

Back to Clinical Guideline Hubs